IMP
Process View
response to dexamethasone
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to dexamethasone"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ESR1 | estrogen receptor 1 | 0.270 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.189 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.131 | ||
| NRP1 | neuropilin 1 | 0.122 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.121 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.118 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.104 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.094 | ||
| PLAU | plasminogen activator, urokinase | 0.084 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.067 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.062 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.062 | ||
| ENG | endoglin | 0.057 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.053 | ||
| FSTL1 | follistatin-like 1 | 0.052 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.041 | ||
| MYLK2 | myosin light chain kinase 2 | 0.040 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.038 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.037 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.036 | ||
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.036 | ||
| ARRDC3 | arrestin domain containing 3 | 0.033 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.033 | ||
| NEB | nebulin | 0.032 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.031 | ||
| ACTN2 | actinin, alpha 2 | 0.030 | ||
| EGFR | epidermal growth factor receptor | 0.030 | ||
| IRS1 | insulin receptor substrate 1 | 0.029 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.029 | ||
| TTN | titin | 0.029 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.029 | ||
| PGF | placental growth factor | 0.028 | ||
| MRPL41 | mitochondrial ribosomal protein L41 | 0.027 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.026 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.025 | ||
| PRDX1 | peroxiredoxin 1 | 0.025 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.025 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.025 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.023 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.022 | ||
| TRIM55 | tripartite motif containing 55 | 0.022 | ||
| THBS1 | thrombospondin 1 | 0.022 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.021 | ||
| GFM1 | G elongation factor, mitochondrial 1 | 0.021 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.021 | ||
| DYNLT1 | dynein, light chain, Tctex-type 1 | 0.020 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.020 | ||
| TCAP | titin-cap (telethonin) | 0.020 | ||
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.020 | ||
| ACTA1 | actin, alpha 1, skeletal muscle | 0.019 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.019 | ||
| NOMO1 | NODAL modulator 1 | 0.019 | ||
| DES | desmin | 0.019 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.019 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.019 | ||
| RARA | retinoic acid receptor, alpha | 0.018 | ||
| MDFI | MyoD family inhibitor | 0.017 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.017 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.017 | ||
| ARRB1 | arrestin, beta 1 | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.017 | ||
| EZH2 | enhancer of zeste homolog 2 (Drosophila) | 0.017 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.017 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.016 | ||
| IL8 | interleukin 8 | 0.016 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.016 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.016 | ||
| CMIP | c-Maf-inducing protein | 0.016 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.016 | ||
| ORM1 | orosomucoid 1 | 0.016 | ||
| TUBA1A | tubulin, alpha 1a | 0.015 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.015 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.015 | ||
| MYOZ1 | myozenin 1 | 0.015 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.015 | ||
| INSR | insulin receptor | 0.015 | ||
| GRIP1 | glutamate receptor interacting protein 1 | 0.014 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.014 | ||
| AXL | AXL receptor tyrosine kinase | 0.014 | ||
| H3F3C | H3 histone, family 3C | 0.014 | ||
| DCAF6 | DDB1 and CUL4 associated factor 6 | 0.014 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.014 | ||
| BMP2 | bone morphogenetic protein 2 | 0.014 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.014 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.014 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.014 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.013 | ||
| GAS6 | growth arrest-specific 6 | 0.013 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.013 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.013 | ||
| EZR | ezrin | 0.013 | ||
| SIRT2 | sirtuin 2 | 0.013 | ||
| ZNF205 | zinc finger protein 205 | 0.013 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.013 | ||
| PRKCA | protein kinase C, alpha | 0.013 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
| SEC61G | Sec61 gamma subunit | 0.013 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.013 | ||
| TRIM54 | tripartite motif containing 54 | 0.013 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.013 | ||
| EPOR | erythropoietin receptor | 0.013 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.013 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.013 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.013 | ||
| TNNI2 | troponin I type 2 (skeletal, fast) | 0.013 | ||
| TLR3 | toll-like receptor 3 | 0.013 | ||
| VTN | vitronectin | 0.013 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.013 | ||
| GHR | growth hormone receptor | 0.013 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.012 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.012 | ||
| FLNC | filamin C, gamma | 0.012 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.012 | ||
| MEF2A | myocyte enhancer factor 2A | 0.012 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.012 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.012 | ||
| FAM107A | family with sequence similarity 107, member A | 0.012 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.012 | ||
| CD4 | CD4 molecule | 0.012 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.012 | ||
| FOXO1 | forkhead box O1 | 0.012 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.011 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.011 | ||
| CAPN3 | calpain 3, (p94) | 0.011 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.011 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.011 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.011 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.011 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.011 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.011 | ||
| MYOD1 | myogenic differentiation 1 | 0.011 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.011 | ||
| LMCD1 | LIM and cysteine-rich domains 1 | 0.011 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.011 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.011 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.011 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.011 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.011 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.011 | ||
| UBQLN4 | ubiquilin 4 | 0.010 | ||
| FBLN1 | fibulin 1 | 0.010 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.010 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.010 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.010 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.010 | ||
| LDLR | low density lipoprotein receptor | 0.010 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.010 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.010 | ||
| TNNI3 | troponin I type 3 (cardiac) | 0.010 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.010 |